55 6. ASSESSMENT › 6.1. Existence of aid › Involvement of State resources, Decision_act (EU) 2015/1300

In forcesince 27 Mar 2015

In the case at hand the relevant German legislation (through the price moratorium and the manufacturer's rebate) lays down the price that the insurance funds have to pay for pharmaceutical products. By granting the exemptions under assessment, the BAFA (a federal authority) ensures that these funds pay a higher price for the products in question, namely products of companies deemed to be in sufficient financial difficulty to justify an exception to the generally applicable fixed price.